North America Pharmaceutical Intermediates Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Pharmaceutical Intermediates Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Pharmaceutical Intermediates Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Pharmaceutical Intermediates Market Regional Analysis

6.2 North America Pharmaceutical Intermediates Market Revenue 2019-2028 (US$ Million)

6.3 North America Pharmaceutical Intermediates Market Forecast Analysis

7. North America Pharmaceutical Intermediates Market Analysis – by Type

7.1 GMP

7.1.1 Overview
7.1.2 GMP: North America Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Non GMP

7.2.1 Overview
7.2.2 Non GMP: North America Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Pharmaceutical Intermediates Market Analysis – by Application

8.1 Antibiotics

8.1.1 Overview
8.1.2 Antibiotics: North America Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Antipyretic Analgesics

8.2.1 Overview
8.2.2 Antipyretic Analgesics: North America Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Vitamins

8.3.1 Overview
8.3.2 Vitamins: North America Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Pharmaceutical Intermediates Market Analysis – by Distribution Channel

9.1 Distributor

9.1.1 Overview
9.1.2 Distributor: North America Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Direct Sales

9.2.1 Overview
9.2.2 Direct Sales : North America Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Pharmaceutical Intermediates Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Pharmaceutical Intermediates Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Pharmaceutical Intermediates Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Pharmaceutical Intermediates Market Breakdown, by Type
10.2.1.1.2 US: North America Pharmaceutical Intermediates Market Breakdown, by Application
10.2.1.1.3 US: North America Pharmaceutical Intermediates Market Breakdown, by Distribution Channel

10.2.1.2 Canada: North America Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Pharmaceutical Intermediates Market Breakdown, by Type
10.2.1.2.2 Canada: North America Pharmaceutical Intermediates Market Breakdown, by Application
10.2.1.2.3 Canada: North America Pharmaceutical Intermediates Market Breakdown, by Distribution Channel

10.2.1.3 Mexico : North America Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Pharmaceutical Intermediates Market Breakdown, by Type
10.2.1.3.2 Mexico : North America Pharmaceutical Intermediates Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Pharmaceutical Intermediates Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 BASF SE

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 chiracon GmbH

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Codexis

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Dishman Carbogen Amcis Ltd

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Midas Pharma GmbH

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Pfizer Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Sanofi

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Vertellus Holdings LLC

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Pharmaceutical Intermediates Market

Analysis By Type (GMP and Non GMP), Application (Antibiotics, Antipyretic Analgesics, Vitamins, and Others), and Distribution Channel (Distributor and Direct Sales)